Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010–2015
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010–2015
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 16, Issue 6, Pages 689-700
Publisher
Informa UK Limited
Online
2016-04-09
DOI
10.1080/14737175.2016.1176531
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Agents for Relapsing Forms of Multiple Sclerosis
- (2016) Rebecca Straus Farber et al. Annual Review of Medicine
- Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease
- (2016) Steven J. Greenberg et al. Therapeutic Advances in Neurological Disorders
- Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications
- (2015) Mathilde Versini et al. BMC Medicine
- Disposition of Flavonoids Impacts their Efficacy and Safety
- (2015) Yong Ma et al. CURRENT DRUG METABOLISM
- ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
- (2015) Robert C. Sergott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies
- (2015) Jesus Lovera et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect
- (2015) A Voldsgaard et al. Multiple Sclerosis Journal
- Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect
- (2015) A Voldsgaard et al. Multiple Sclerosis Journal
- The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
- (2014) Helena Marco et al. BMC MUSCULOSKELETAL DISORDERS
- Regulatory T cells in autoimmune neuroinflammation
- (2014) Markus Kleinewietfeld et al. IMMUNOLOGICAL REVIEWS
- Therapeutic uses of anti- 4-integrin (anti-VLA-4) antibodies in multiple sclerosis
- (2014) N. Schwab et al. INTERNATIONAL IMMUNOLOGY
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
- (2014) Thomas P Leist et al. LANCET NEUROLOGY
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- 2 1 Integrin Regulates Th17 Cell Activity and Its Neutralization Decreases the Severity of Collagen-Induced Arthritis
- (2013) M.-A. El Azreq et al. JOURNAL OF IMMUNOLOGY
- Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients
- (2013) L. Michel et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks
- (2013) Srdjan Ljubisavljevic et al. METABOLIC BRAIN DISEASE
- Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
- (2013) Berit Rosche et al. Trials
- Polyunsaturated fatty acids in multiple sclerosis therapy
- (2012) S. Wergeland et al. ACTA NEUROLOGICA SCANDINAVICA
- ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study)
- (2012) Øivind Torkildsen et al. ARCHIVES OF NEUROLOGY
- Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor-Negative Breast Cancer
- (2012) K. D. Crew et al. Cancer Prevention Research
- Urate in Parkinson’s Disease: More Than a Biomarker?
- (2012) Xiqun Chen et al. Current Neurology and Neuroscience Reports
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival
- (2012) X. Ou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Toxicity and Pathology of Selected Dietary Herbal Medicines
- (2012) June K. Dunnick et al. TOXICOLOGIC PATHOLOGY
- Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets
- (2011) Junpeng Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
- (2011) A. Cuker et al. BLOOD
- Cladribine
- (2011) Thomas P. Leist et al. CLINICAL NEUROPHARMACOLOGY
- How do immune cells overcome the blood-brain barrier in multiple sclerosis?
- (2011) Catherine Larochelle et al. FEBS LETTERS
- Progressive multifocal leukoencephalopathy and natalizumab
- (2011) Kerstin Hellwig et al. JOURNAL OF NEUROLOGY
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
- (2011) Per Soelberg Sorensen et al. LANCET NEUROLOGY
- Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study
- (2011) JO Fleming et al. Multiple Sclerosis Journal
- Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
- (2011) S Cook et al. Multiple Sclerosis Journal
- Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
- (2011) Katja Herges et al. PLoS One
- Therapeutic Approaches to Multiple Sclerosis
- (2010) Sven G. Meuth et al. BIODRUGS
- Therapeutic Approaches to Multiple Sclerosis
- (2010) Jochen C. Ulzheimer et al. BIODRUGS
- Alpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells
- (2010) Marc Boisvert et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
- (2010) Christopher T. Harp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon β in relapsing- remitting Multiple Sclerosis (ASIIMS) trial
- (2010) Richard E Gonsette et al. Multiple Sclerosis Journal
- Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: Outcomes in 102 patients
- (2010) Michael K. Hehir et al. MUSCLE & NERVE
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing—remitting multiple sclerosis (TIME MS)
- (2010) Gina M. Remington et al. Therapeutic Advances in Neurological Disorders
- A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis
- (2010) Elliot M. Frohman et al. Therapeutic Advances in Neurological Disorders
- Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
- (2009) Anu Jacob et al. ARCHIVES OF NEUROLOGY
- Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling
- (2009) Dayong Wu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs
- (2009) I.M. Kapetanovic et al. TOXICOLOGY
- Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis
- (2009) Lahar R Mehta et al. Nature clinical practice. Neurology
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties
- (2008) Fabienne Mackay et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
- (2008) R.E. Gonsette JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Complementary and alternative medicine for multiple sclerosis
- (2008) S Schwarz et al. Multiple Sclerosis Journal
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started